To improve the design and efficacy of potential drugs, precludes the formation of a productive conformation.
lytic cleavage after Asp198 gives rise to a fully active ( Figure 2A ). However, in the procaspase-7 zymogen, loop L2Ј is flipped by 180Њ, disallowing the formation of caspase-7. To prevent this proteolytic activation, we mutated the catalytic residue Cys186 to Ala. This prothis loop-bundle structure. These structural rearrangements explain why the procaspase-7 zymogen does not caspase-7 variant (C186A) was expressed as a single contiguous polypeptide, purified to homogeneity, and possess detectable catalytic activity. The procaspase-7 zymogen is a single contiguous crystallized. The structure was determined by molecular polypeptide chain, with loop L2 linking the large and replacement and refined at 2.7 Å resolution with crystalthe small subunits. This interdomain loop contains the lographic working and free R factors of 22.7% and cleavage site (Ile195-Gln196-Ala197-Asp198) for the ac-25.3%, respectively (Table 1 and Figure 1) . tivation of procaspase-7, which requires a certain deSimilar to the active caspase-7, the procaspase-7 zygree of flexibility in this region for binding to the active mogen comprises two catalytic units, each containing sites. In the crystals, there was no clear electron dena central 6-stranded ␤ sheet and five ␣ helices (Figure sity for part of the L2 loop (residues 190-203) that cen-1A). Four surface loops (L1-L4) emanate from these core ters on the cleavage site, confirming that these regions structural elements, forming a potential catalytic site.
are indeed highly flexible and disordered in solution Compared to the inhibitor-bound caspase-7 (Chai et ( Figure 1A ). al., 2001), the core structural elements remain nearly Each heterodimer of caspase-7 may be derived from identical, with less than 0.8 Å root-mean-square deviathe same polypeptide chain, or from two separate polytion (Rmsd) for all 360 aligned C␣ atoms ( Figure 1B) . peptide chains as proposed by an interdigitating model. However, three of the four active site loops adopt drastiThese two models cannot by distinguished by in vivo cally different conformations ( Figures 1B and 1C Figure 1C ). Most importantly, loop L2, which terminus of the large subunit in the same heterodimer, as contains the catalytic residue Cys186, changes its direcjudged by electron density ( Figure 1A ). This arrangement tion by 90Њ and makes this residue inaccessible to solsupports the conclusion that each heterodimer results vent ( Figure 1C ). Among the four loops, only L1 retains from the same polypeptide. Based on this observation, its active site conformation ( Figure 1C) .
we term the two interdomain loops L2 and L2Ј, respecCompared to the catalytic groove in the active castively ( Figure 1A ). pase-7 formed by the four loops ( Figure 1D ), these structural rearrangements in the procaspase-7 zymogen do not give rise to a recognizable substrate binding site Structural Rearrangements in the Loop-Bundle ( Figure 1E ). In particular, loops L4, L2, and L2Ј form
In the active caspase-7 bound with peptide inhibitors, a "loop-bundle" through numerous interactions in the the catalytic groove is well defined by four surrounding inhibitor-bound caspase-7 (Chai et al. hand, is involved in networks of contacts with the L4 not only stabilize the L2 loop but also engage the L4 loop to maintain a productive conformation for the cataand L2Ј loops, forming the so-called loop-bundle ( Figure  2A ). There are a total of 11 hydrogen bonds and numerlytic cleft to which the inhibitors/substrates bind. In the procaspase-7 zymogen, the loop-bundle is ous van der Waals interactions in the loop-bundle region, centering on residues Asp192 of the L2 loop and completely dissolved ( Figure 2B ). Rather than engaging the N-terminal portions of loops L2 and L4, the N termiPro214 of the L2Ј loop (Figure 2A ). These interactions Why is there such a drastic conformational change conserved. These observations suggest that the activation mechanism observed for caspase-7 is likely true between the procaspase-7 zymogen and the inhibitor- To confirm this conclusion, we generated three caspase-7 variants ( Figure 3A) , each of which contains an invariant large subunit (residues 51-198) and a distinct small subunit. This was achieved by coexpression of the large subunit in one vector and the small subunit in another compatible vector in bacteria (see Experimental Procedures). Thus, these caspase-7 variants represent their "cleaved" or "active" form. The only difference is that, relative to the wild-type (wt) caspase-7, the ⌬S and ⌬L variants contain deletion of residues 199-205 and 199-215, respectively ( Figure 3A) . Since the removal of residues 212-215 eliminates the formation of the loop- Next, we examined the catalytic activity of these casin procaspase-9, producing a p37 large subunit and a p10 small subunit. To prevent autocleavage, we mutated pase-7 variants, using procaspase-9 as a substrate (Figure 3C ). Caspase-7 is able to cleave after residue Asp330 the catalytic residue Cys286 to Ala in the full-length procaspase-9 (residues 1-416) and purified the resultgers a 180Њ flipping of the L2Ј loop in the active caspase-7, changing its closed conformation in the isolated ing protein to homogeneity. Equal amounts of the caspase-7 variants were incubated with the procaspase-9 caspase-7 to an open form in the loop-bundle in the inhibitor-bound caspase-7. This movement is appar-(C286A) substrate; the cleavage efficiency was monitored by SDS-PAGE and Coomassie staining (Figure ently prohibited in the procaspase-7 zymogen prior to cleavage at Asp198. Therefore, the procaspase-7 zymo-3C). In agreement with the binding results ( Figure 3B ), caspase-7 (⌬S) displayed the same level of catalytic gen is unable to interact with substrates or inhibitors ( Figure 3B ). activity as the wt protein, whereas caspase-7 (⌬L) was only marginally active ( Figure 3C) . Thus, the interdomain cleavage initiates a conformational change in the active site loops and primes caspase-7 for substrate/inhibitor binding, and the actual Structure of an Isolated Active Caspase-7 binding by substrates/inhibitors completes the conforTo further investigate the mechanisms of caspase-7 acmational change to a fully productive state ( Figure 5 ). tivation, we crystallized the active caspase-7 free from
The intrinsic conformational flexibility of the active site any bound inhibitors and determined its structure at loops constitutes an important consideration for the de-2.6 Å resolution ( Figure 4A and Table 1 ). The space sign and screening of caspase inhibitors. group for the crystals of this caspase-7 is P3 2 21, the same as that for the procaspase-7 zymogen and that for the active caspase-7 bound with a peptide inhibitor Discussion (Chai et al., 2001; Huang et al., 2001 ). This facilitates comparisons among the three structures, as they share Our structural analyses demonstrate that the conformation of the active site loops of procaspase-7 zymogen, the same set of crystal lattice contacts. Surprisingly, although the isolated active caspase-7 particularly that of the L2Ј and L2 loops, is ineffective for substrate/inhibitor binding. The underlying restraint is somewhat more similar to the inhibitor-bound caspase-7 than the procaspase-7 zymogen, significant is the covalent linkage in the interdomain region that precludes the formation of a productive conformation structural differences remain ( Figure 4B ). Most strikingly, despite cleavage after Asp198, the loop L2Ј in the ( Figure 5 ). Cleavage after Asp198 leads to some rearrangement in loops L2, L3, and L4 ( Figure 4C ), which isolated caspase-7 still exists in the closed conformation, mimicking the procaspase-7 zymogen ( Figure 4A Figure 2D ) and are visible in the electron density map. However, these residues are not involved in multiple ionic interactions in the crystal structure. In our own experience, the reasons for increased proenzyme dormancy are hard to pinpoint, particularly in the absence of relevant structural information. For example, the missense mutation D168A in procaspase-7 significantly increased its proenzyme dormancy (our unpublished data). Our structural studies, together with published evidence (Srinivasula et al., 1998a, 1998b; Wang  et al., 1999) , unambiguously demonstrate that the proenzyme dormancy of caspases is predominantly due to the covalent linkage between the large and the small subunits.
The activation mechanism of procaspase-7 bears an interesting analogy to the serpin-mediated inhibition of serine proteases. A prototypical serpin, ␣1-antitrypsin, inhibits the catalytic activity of trypsin by covalently trapping trypsin through an ester linkage; the serpin-bound protease undergoes dramatic conformational change and exhibits a deformed catalytic site (Huntington et peptide, a conclusion further supported by recent in In this mechanism, the ability of loop L2Ј to move freely vitro studies using recombinant proteins (Srinivasula et in response to inhibitor/substrate binding is a decisive al., 1998a, 1998b). Moreover, the directions of the L2 feature. In caspase-7, this ability is acquired through and L2Ј loops in procaspase-7 make the other model, proteolytic cleavage after Asp198. Because L2Ј is at the in which the interdomain sequence would have to adopt N terminus of the small subunit, our findings predict that severely restrained conformation, highly unlikely. inverting the order of primary sequences of the large and In summary, our structural analyses reveal the mechasmall subunits might constitutively activate caspase-7.
nisms of caspase-7 activation and the induced-fit nature Although it remains to be formally proved for caspase-7, of substrate/inhibitor binding for caspase-7. These conthis prediction has been confirmed for two other human clusions are likely applicable to other caspases and effector caspases, caspase-3 and -6 (Srinivasula et al.,
should serve a general framework for the understanding 1998b) and the Drosophila caspase drICE (Wang et al., of caspases. 1999). Moreover, the catalytic activity of this reversed caspase-3 does not require the interdomain cleavage 
